Cargando…
SARS-CoV-2 antibody status at time of delivery and the risk of preeclampsia
Autores principales: | Portmann-Baracco, Arianna, Alcorta-Proaño, Rodrigo, Nuñez-Mochizaki, Claudia, Webb, Camille, Trelles, Juan, Caparo, Carlos, La Rosa, Mauricio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696661/ http://dx.doi.org/10.1016/j.ajog.2021.11.1178 |
Ejemplares similares
-
CD4+ T-Cells cause cognitive dysfunction in preeclampsia or COVID-19 infection in a pregnant rat model
por: Sullivan, Kimberly S., et al.
Publicado: (2023) -
1094 Investigating decreased rates of nulliparous Cesarean deliveries during the COVID-19 pandemic
por: Sinnott, Colleen, et al.
Publicado: (2021) -
993 Did health care delivery changes driven by COVID alter pregnancy and postpartum visits?
por: Facco, Francesca, et al.
Publicado: (2021) -
A multi-state analysis of breakthrough COVID-19 infection by vaccination status in the United States
por: Darwin, Kristin C., et al.
Publicado: (2023) -
Higher rates of false-positive HIV antigen/antibody screens during the COVID-19 pandemic: implications for pregnant patients
por: Miller, Madison E., et al.
Publicado: (2023)